75 results
8-K
EX-99.1
BLFS
Biolife Solutions Inc
23 Oct 23
BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023
4:41pm
, “With third quarter cell processing revenue results coming in as expected and our focused strategy for 2024, I believe this is a good time to hand over
8-K
EX-99.1
BLFS
Biolife Solutions Inc
31 Aug 23
Regulation FD Disclosure
5:15pm
% Total $144.0 $158.0 (11)% (2)% (3)% 6%
BioLife Solutions Investor Presentation : August 20239 Focus & Strategy Protect and grow cell processing
8-K
EX-99.1
qtey71v944fluig
10 May 23
BioLife Solutions Reports First Quarter 2023 Financial Results
4:46pm
8-K
EX-99.1
npjtzsc3sto42w7 1lj7
9 Nov 22
BioLife Solutions Reports Third Quarter 2022 Financial Results
4:11pm
S-8
e1moay l0x
12 Sep 22
Registration of securities for employees
5:16pm
8-K
EX-99.1
u16odw4hc4iy9d6
9 Aug 22
BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance
12:00am
8-K
EX-99.1
xopbur63xu jx
9 May 22
BioLife Solutions Reports First Quarter 2022 Financial Results
4:07pm
8-K
EX-99.1
1abasx3jnfc21utiwq1
28 Feb 22
BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results
5:25pm